Consequently, a statistically significant result could not be stated for either the comparison of VEGF levels prior and subsequent to multimodal treatment or for the comparison of the levels in healthy controls and patients with HNSCC. This evidence concerns the gene VEGFA and head and neck squamous cell carcinoma.